Literature DB >> 16026809

Novel alpha-KTx peptides from the venom of the scorpion Centruroides elegans selectively blockade Kv1.3 over IKCa1 K+ channels of T cells.

Timoteo Olamendi-Portugal1, Sándor Somodi, Juan Antonio Fernández, Fernando Z Zamudio, Baltazar Becerril, Zoltán Varga, Gyorgy Panyi, Rezso Gáspár, Lourival D Possani.   

Abstract

From the venom of the Mexican scorpion Centruroides elegans Thorell five peptides were isolated to homogeneity by chromatographic procedures and their full amino acid sequence was determined by automatic Edman degradation. They all belong to the Noxiustoxin subfamily of scorpion toxins and were given the systematic names alpha-KTx 2.8 to 2.12, with trivial names Ce1 to Ce5, respectively. They have 39 amino acid residues, except for Ce3 which has only 38, but all of them have three disulfide bridges, and have molecular weights of 4255, 4267, 4249, 4295 and 4255 atomic mass units, respectively for Ce1 to Ce5. The C-terminal residues of Ce2, Ce4 and Ce5 were found to be amidated. The electrophysiological assay (whole-cell patch-clamp) showed that out of the five peptides, Ce1 (alpha-KTx 2.8), Ce2 (alpha-KTX2.9) and Ce4 (alpha-KTx 2.11) were effective blockers of Kv1.3 channels of human T lymphocytes, whereas these peptides did not inhibit the Ca2+-activated K+ channels (IKCa1) of the same cells. The equilibrium dissociation constants of these peptides for Kv1.3 were 0.70, 0.25 and 0.98nM for Ce1, Ce2 and Ce4, respectively. Furthermore, toxins Ce1, Ce2 and Ce4 practically did not inhibit the related voltage gated Shaker K+ channels, and rKv2.1 channels of the Shab family. The high affinity blockage of Kv1.3 channels by these peptides and their selectivity for Kv1.3 over IKCa1 may have significance in the development of novel tools for suppressing the function of those T cell subsets whose proliferation critically depends on the activity of Kv1.3 channels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026809     DOI: 10.1016/j.toxicon.2005.06.001

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  6 in total

1.  A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library.

Authors:  Zoltan Takacs; Megan Toups; Astrid Kollewe; Erik Johnson; Luis G Cuello; Gregory Driessens; Matthew Biancalana; Akiko Koide; Cristiano G Ponte; Eduardo Perozo; Thomas F Gajewski; Guilherme Suarez-Kurtz; Shohei Koide; Steve A N Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

2.  Two novel ergtoxins, blockers of K+-channels, purified from the Mexican scorpion Centruroides elegans elegans.

Authors:  Rita Restano-Cassulini; Timoteo Olamendi-Portugal; Fernando Zamudio; Baltazar Becerril; Lourival Domingos Possani
Journal:  Neurochem Res       Date:  2008-03-13       Impact factor: 3.996

3.  Developing a comparative docking protocol for the prediction of peptide selectivity profiles: investigation of potassium channel toxins.

Authors:  Po-Chia Chen; Serdar Kuyucak
Journal:  Toxins (Basel)       Date:  2012-02-06       Impact factor: 4.546

4.  Structural and functional diversity of acidic scorpion potassium channel toxins.

Authors:  Zong-Yun Chen; Dan-Yun Zeng; You-Tian Hu; Ya-Wen He; Na Pan; Jiu-Ping Ding; Zhi-Jian Cao; Mai-Li Liu; Wen-Xin Li; Hong Yi; Ling Jiang; Ying-Liang Wu
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

Review 5.  Placing ion channels into a signaling network of T cells: from maturing thymocytes to healthy T lymphocytes or leukemic T lymphoblasts.

Authors:  Oxana Dobrovinskaya; Iván Delgado-Enciso; Laura Johanna Quintero-Castro; Carlos Best-Aguilera; Rocío Monserrat Rojas-Sotelo; Igor Pottosin
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

6.  Intraspecific variation of centruroides edwardsii venom from two regions of Colombia.

Authors:  Sebastián Estrada-Gómez; Nelson Ivan Cupitra; Walter Murillo Arango; Leidy Johana Vargas Muñoz
Journal:  Toxins (Basel)       Date:  2014-07-14       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.